Dr. Vandermolen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
330 Old Newport Blvd
Newport Beach, CA 92663Phone+1 949-646-6441Fax+1 949-646-5719- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
- Baylor College of MedicineFellowship, Hematology, 1983 - 1984
- Methodist Hospital (Houston)Chief Residency, Internal Medicine, 1983 - 1984
- Baylor College of MedicineResidency, Internal Medicine, 1980 - 1983
- Loyola University Chicago Stritch School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1983 - 2025
- AR State Medical License 1986 - 1991
- MD State Medical License 1987 - 1991
- TN State Medical License 1989 - 1990
- TX State Medical License 1981 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 16 citationsShould high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma?Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen, Khosrow Mahdavi, Stephanie E. McClure> ;Cancer Biotherapy & Radiopharmaceuticals. 2012 Jul 17
- 2 citationsA retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced ...Brian S. Kim, Robert O. Dillman, Peter Chen, Russell Hafer, Craig Cox, Neil M. Barth, R. Matthew Carroll, Louis A. VanderMolen, Minh Nguyen, JinChu Huang, Annamarie Mi...> ;American Journal of Otolaryngology. 2012 Jan 1
- 7 citationsShould High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen, Warren H. Fong, Khosrow Mahdavi, Stephanie E. McClure> ;Cancer Biotherapy & Radiopharmaceuticals. 2011 Jul 5
- Join now to see all
Hospital Affiliations
- Hoag Memorial Hospital PresbyterianNewport Beach, California
- Keck Hospital of USCLos Angeles, California
- USC Norris Comprehensive Cancer CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: